The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a CAGR of 4.86% (2025-2033). Growth is driven by rising chronic diseases ...

Former presidential candidate Adi Roche has said those running for the Áras “need to be strong”, citing her experience in a “shockingly dirty campaign” which she said continues to haunt ...

Has David Roche Cracked the Code? Or Is He Just Another Crackpot? The Boulder athlete claims to have developed a radical recipe to revolutionize long-distance running. I decided to find out if his ...

On Monday, Aug. 4, the San Juan County Sheriff’s Office received two reports of a mountain lion sighting. The first call came in around 11:02 am with a caller advising that a lady who was running a ...

Zanubrutinib plus the selective BCL2 inhibitor venetoclax (Venclexta) demonstrated high response rates and a favorable safety profile across CLL patient types in SEQUOIA Arm D, including among ...

Thousands of Medicare recipients will face higher costs for expensive cancer drugs following passage of two provisions in the One Big Beautiful Bill Act, signed by President Donald Trump in July ...

Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in nAMD, the leading cause of vision loss in people over the age of 60 With two refills per year, ...

The company's oncology portfolio is currently bolstered by lucrative drugs like Imbruvica and Venclexta. Its neuroscience portfolio, including drugs like Vraylar and Botox Therapeutic, is also ...

July marks a transformative month in oncology with the FDA's groundbreaking approvals and updates, enhancing treatment options for various cancers.